Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2023-06-29 00:00:00 ET · period of report 2023-06-28 · accession 0000950170-23-030805 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-29 | 2023-06-28 | CGEM | AHMED NADIM | Pres, CEO, Dir | S - Sale | $11.40 | -759 | 115.8K | -0.7% | -$8,653 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-28 | S | D | 759 | $11.40 | 115,822 | D | — | — | (F1) Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. |